The Chronic Cough Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.8 billion by 2034, registering a CAGR of 6.8%. This growth trajectory is underpinned by several factors, including the rising prevalence of chronic respiratory diseases, increased awareness and diagnosis of chronic cough conditions, and advancements in treatment options. The market is experiencing a...